ɬ﷬

Journal News

From the journals: ɬ﷬

Shravanti  Suresh
July 7, 2021

Linking phosphorylation and synaptic vesicles recycling. How kinase responses affect plant development. Identifying protein interactions in prostate cancer. Read about papers on these topics recently published in the journal Molecular & Cellular Proteomics.

Linking phosphorylation and synaptic vesicles recycling

In the nervous system, signals are transmitted through cellular junctions known as synapses from presynaptic neurons to postsynaptic neurons. When an action potential arrives at the nerve terminal, the presynaptic neuron depolarizes and releases an influx of calcium ions through channels in the active zone. This connects the presynaptic neuron to the postsynaptic membrane. These fused synaptic vesicles, or SVs, need to be retrieved and recycled to sustain continuous neurotransmitter release and to maintain the structure and composition of the plasma membrane. Defects in these processes can cause neurological disorders.

Scientists have many hypotheses about the exact mechanism of this endocytosis and vesicle recycling. An increasing body of data points toward phosphorylation and dephosphorylation of proteins involved in the SV recycling as actions regulating this process. While some studies show an indirect relation between the two, changes in protein conformation that accompany assembly and disassembly of protein complexes during SV recycling may affect access to phosphorylation sites. Therefore, we cannot determine the effect of phosphorylation on SV recycling directly.

In published in the journal Molecular & Cellular Proteomics, Ivan Silbern and colleagues at the Max Planck Institute for Biological Chemistry, Germany, used botulinum neurotoxins, or BoNT, to differentiate between calcium-induced changes and phosphorylation events that are linked to SV recycling. By conducting a quantitative phosphoproteomic analysis using synaptosomes as a functional model for a synapse, they identified 1,500 sites that are affected by BoNT treatment, implying a direct connection to SV recycling. They also identified SV-cycling–dependent phosphorylation sites on syntaxin 1a, synaptobrevin and cannabinoid receptor 1.

This study demonstrates that the phosphorylation of these sites on the synaptosome can have a pronounced effect on exocytosis and endocytosis in cultured hippocampal neurons, establishing a firmer link between phosphorylation/dephosphorylation and SV recycling.

Neurons-890x712.jpg
S. Jeong/Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH
In mice with a mutation that causes the progressive neurodegenerative disease amyotrophic lateral sclerosis, a hyperactive enzyme called Cdk5 normally kills spinal cord neurons such as those pictured here.

How kinase responses affect plant development

Protein phosphorylation is an important mechanism that responds to environmental stimuli, especially in eukaryotes. Nearly 4% of the proteins encoded in Arabidopsis plants are protein kinases, suggesting a strong link to protein regulation. In plants, a serine/threonine protein kinase known as the Mut9-like kinase, or MLK, is linked to light, circadian and abiotic stress signaling. Previous studies have shown that MLKs provide a link between light and circadian signaling, which in turn affects plant growth and development. Researchers aim to identify roles of such kinases that use environmental inputs such as light and abiotic stress to generate altered developmental outputs.

In in the journal Molecular & Cellular Proteomics, Margaret Wilson and colleagues at the Donald Danforth Plant Science Center describe using quantitative phosphoproteomics and global proteomic analysis to investigate the role of MLKs in daily protein dynamics. This study shows that in the absence of MLK, many proteins involved in light, circadian and hormone signaling as well as chromatin-modifying enzymes and DNA damage response factors have altered phosphorylation levels. Using several analytic methods, the authors showed that MLKs may help alleviate DNA damage through the regulation of multiple response pathways. They also observed higher levels of glucosinolate accumulation in MLK mutant plants, which could be related to the sensitivity to DNA-damaging agents. This is pivotal in understanding the role of MLK in multiple metabolic pathways that are regulated by this kinase in common.

Identifying protein interactions in prostate cancer

One in nine men are diagnosed with prostate cancer at some point in their lives. The growth and initiation of prostate cancer is caused by the androgen receptor, or AR, NR3C4, a steroid receptor. The AR acts as a transcriptional factor, regulating target genes involved in cell proliferation, survival and growth. While ARs are known to be regulated by several proteins affecting transcriptional location and ligand binding, researchers don’t know the extent of this regulation and aim to identify the AR protein interaction networks to understand better how prostate cancer starts and spreads.

In in the journal Molecular & Cellular Proteomics, Lauriane Vélot and colleagues at the Centre de recherche sur le cancer de l’Université Laval, Quebec, write that they used BioID proximity labeling proteomics, which fuse a mutant biotin ligase with a protein of interest to deduce AR interactions. By applying this in androgen-dependent LAPC4 cells expressing wild-type AR, they were able to indicate precisely a network of 267 proteins, 213 of which had not been reported previously. The authors also identify Kruppel-like factor 4, or KLF4, as a new AR-associated protein that represses KLK3, commonly known as the prostate-specific antigen, without regulating AR expression. The authors speculate that by establishing high confidence interaction networks, they could learn about prostrate cancer’s complexity.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Shravanti  Suresh

Shravanti Suresh is a Ph.D. candidate in Dipali Sashital’s lab at Iowa State University and a volunteer ASBMB Today contributor.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Omega-3 fats linked to healthy aging and improved heart metabolism
Journal News

Omega-3 fats linked to healthy aging and improved heart metabolism

Aug. 1, 2025

Scientists from the University of Iowa find that a diet high in polyunsaturated fatty acids from fish oil increases cardiac triglyceride uptake and improves insulin sensitivity. Read more about this recent JLR study.

RA patient blood reveals joint innerworkings
Journal News

RA patient blood reveals joint innerworkings

July 25, 2025

Researchers in the Netherlands use mass spectrometry to compare the proteome of plasma and synovial fluid in rheumatoid arthritis patients and find a correlation. Read more about this recent paper in Molecular & Cellular Proteomics.

Hope for a cure hangs on research
Essay

Hope for a cure hangs on research

July 17, 2025

Amid drastic proposed cuts to biomedical research, rare disease families like Hailey Adkisson’s fight for survival and hope. Without funding, science can’t “catch up” to help the patients who need it most.

Before we’ve lost what we can’t rebuild: Hope for prion disease
Feature

Before we’ve lost what we can’t rebuild: Hope for prion disease

July 15, 2025

Sonia Vallabh and Eric Minikel, a husband-and-wife team racing to cure prion disease, helped develop ION717, an antisense oligonucleotide treatment now in clinical trials. Their mission is personal — and just getting started.

Defeating deletions and duplications
News

Defeating deletions and duplications

July 11, 2025

Promising therapeutics for chromosome 15 rare neurodevelopmental disorders, including Angelman syndrome, Dup15q syndrome and Prader–Willi syndrome.

Using 'nature’s mistakes' as a window into Lafora disease
Feature

Using 'nature’s mistakes' as a window into Lafora disease

July 10, 2025

After years of heartbreak, Lafora disease families are fueling glycogen storage research breakthroughs, helping develop therapies that may treat not only Lafora but other related neurological disorders.